Weers JG - Search Results

1

Idealhalers Versus Realhalers: Is It Possible to Bypass Deposition in the Upper Respiratory Tract?

Weers JG, Son YJ, Glusker M, Haynes A, Huang D, Kadrichu N, Le J, Li X, Malcolmson R, Miller DP, Tarara TE, Ung K, Clark A. Weers JG, et al. J Aerosol Med Pulm Drug Deliv. 2019 Apr;32(2):55-69. doi: 10.1089/jamp.2018.1497. Epub 2018 Dec 6. J Aerosol Med Pulm Drug Deliv. 2019. PMID: 30481087 Review.

2

Stabilization of perflubron emulsions with egg yolk phospholipid.

Pelura TJ, Johnson CS, Tarara TE, Weers JG. Pelura TJ, et al. Among authors: weers jg. Biomater Artif Cells Immobilization Biotechnol. 1992;20(2-4):845-8. doi: 10.3109/10731199209119728. Biomater Artif Cells Immobilization Biotechnol. 1992. PMID: 1391521

3

Hollow porous particles in metered dose inhalers.

Dellamary LA, Tarara TE, Smith DJ, Woelk CH, Adractas A, Costello ML, Gill H, Weers JG. Dellamary LA, et al. Among authors: weers jg. Pharm Res. 2000 Feb;17(2):168-74. doi: 10.1023/a:1007513213292. Pharm Res. 2000. PMID: 10751031

4

Novel lipid-based hollow-porous microparticles as a platform for immunoglobulin delivery to the respiratory tract.

Bot AI, Tarara TE, Smith DJ, Bot SR, Woods CM, Weers JG. Bot AI, et al. Among authors: weers jg. Pharm Res. 2000 Mar;17(3):275-83. doi: 10.1023/a:1007544804864. Pharm Res. 2000. PMID: 10801215

5

Receptor-mediated targeting of spray-dried lipid particles coformulated with immunoglobulin and loaded with a prototype vaccine.

Bot AI, Smith DJ, Bot S, Dellamary L, Tarara TE, Harders S, Phillips W, Weers JG, Woods CM. Bot AI, et al. Among authors: weers jg. Pharm Res. 2001 Jul;18(7):971-9. doi: 10.1023/a:1010988311640. Pharm Res. 2001. PMID: 11496957

6

Liquid dose pulmonary instillation of gentamicin PulmoSpheres formulations: tissue distribution and pharmacokinetics in rabbits.

Smith DJ, Gambone LM, Tarara T, Meays DR, Dellamary LA, Woods CM, Weers J. Smith DJ, et al. Pharm Res. 2001 Nov;18(11):1556-61. doi: 10.1023/a:1013078330485. Pharm Res. 2001. PMID: 11758763

7

Improved lung delivery from a passive dry powder inhaler using an Engineered PulmoSphere powder.

Duddu SP, Sisk SA, Walter YH, Tarara TE, Trimble KR, Clark AR, Eldon MA, Elton RC, Pickford M, Hirst PH, Newman SP, Weers JG. Duddu SP, et al. Among authors: weers jg. Pharm Res. 2002 May;19(5):689-95. doi: 10.1023/a:1015322616613. Pharm Res. 2002. PMID: 12069174 Clinical Trial.

8

Inhalation of a dry powder tobramycin PulmoSphere formulation in healthy volunteers.

Newhouse MT, Hirst PH, Duddu SP, Walter YH, Tarara TE, Clark AR, Weers JG. Newhouse MT, et al. Among authors: weers jg. Chest. 2003 Jul;124(1):360-6. doi: 10.1378/chest.124.1.360. Chest. 2003. PMID: 12853545

9

Characterization of fluorocarbon-in-water emulsions with added triglyceride.

Weers JG, Arlauskas RA, Tarara TE, Pelura TJ. Weers JG, et al. Langmuir. 2004 Aug 31;20(18):7430-5. doi: 10.1021/la049375e. Langmuir. 2004. PMID: 15323486

10

Characterization of suspension-based metered dose inhaler formulations composed of spray-dried budesonide microcrystals dispersed in HFA-134a.

Tarara TE, Hartman MS, Gill H, Kennedy AA, Weers JG. Tarara TE, et al. Among authors: weers jg. Pharm Res. 2004 Sep;21(9):1607-14. doi: 10.1023/b:pham.0000041455.13980.f1. Pharm Res. 2004. PMID: 15497686

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page